Glycerol phenylbutyrate
Ravicti (glycerol phenylbutyrate) is a small molecule pharmaceutical. Glycerol phenylbutyrate was first approved as Ravicti on 2013-02-01. It has been approved in Europe to treat inborn urea cycle disorders. Ravicti's patent is valid until 2032-03-09 (FDA).
| Trade Name | Ravicti |
|---|---|
| Common Name | Glycerol phenylbutyrate |
| Indication | inborn urea cycle disorders |
| Drug Class |
